Comvita Fresh-Picked™ Olive Leaf celebrates scientific success

31/03/2013

Comvita Fresh-Picked™ Olive Leaf celebrates scientific success

A clinical trial in 2012 by researchers at the University of Auckland’s Liggins Institute showed that Comvita’s extract of Fresh-Picked™ olive leaves appreciably reduced some risk factors for developing Type 2 Diabetes.

Principal Investigator and Liggins Institute Director Professor Wayne Cutfield said that supplementation with Comvita Fresh-Picked Olive Leaf Extract for 12 weeks improved the way that insulin was secreted and worked in overweight men. Insulin is an important hormone which controls metabolism by stimulating the transport of glucose and fat into cells.

“We saw significant improvements in standard measures of insulin action and secretion compared with placebo. The changes were of similar magnitude to those achieved with the commonly prescribed diabetes medication metformin, suggesting that these results could also have clinical relevance for patients with type 2 diabetes,” said Cutfield.

Direct excerpt from: Comvita. (2013). Comvita 2013 Annual report. Retrieved from Page 13 of http://www.comvita.co.nz/_assets/Investors/Results-and-Reporting/Year-ended-31-March-2013/31March2013CVTAnnualReport.pdf

 

Read other Olive Leaf Articles: